The character of heparin-independent aggregation and cytotoxicity is critically advantageous over the unmodified tau that has been used in multiple futile drug screens45–49, for the pathophysiological relevance of heparin in AD remains elusive. The gene discussed is MAPT; the disease is Alzheimer disease.